1.
A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension
by Olsen, Michael H, DMSc
The Lancet (British edition), 2016, Vol.388 (10060), p.2665-2712
2.
Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trial
by Neal, Bruce, PhD
The American heart journal, 2013, Vol.166 (2), p.217-223.e11
3.
Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials
by Heerspink, Hiddo J Lambers, PharmD
The Lancet (British edition), 2009, Vol.373 (9668), p.1009-1015
4.
The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study
by Oshima, Megumi
Diabetologia, 2019-07-13, Vol.62 (11), p.1988-1997
5.
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data
by Sundström, Johan
The Lancet (British edition), 2014-08-16, Vol.384 (9943), p.591-598
6.
Routine blood pressure lowering and intensive glucose control in patients with Type 2 diabetes: the ADVANCE trial
by Joshi, Rohina
Expert review of endocrinology & metabolism, 2009-03-01, Vol.4 (2), p.111-118
Filter electronic articles 6 Hits
Remove Filters
- Subjects
- Health Aspects
- Science & Technology (5)
- Life Sciences & Biomedicine (5)
- more ...